Augment your EMR data with longitudinal patient tracking. Increase your understanding of the impact of therapy in specific patient populations.
AdvanceIQ Network offers evidence panel studies, which are new, evolving studies that allow practices to augment EMR data with additional patient attributes and disease elements. These studies provide longitudinal patient tracking after a clinical trial concludes. This longitudinal data may then inform the type of patients you select for future clinical trials.
Practices may also utilize evidence panel studies in order to monitor a specific patient population in a real world setting. The study collects incremental information in order to better understand the impact of therapy in this patient population.
The ability to enhance your EMR’s traditional data can potentially increase your success with future clinical trials while improving patient health.